The global blaze created by COVID-19 has led to an increase in the consumption of antibiotics. Although there has been a growth in the antimicrobial stewardship activities as compared to the past, we definitely need to lay focus on infection prevention and control measures, with special emphasis on reduction in Antimicrobial Resistance (AMR). Further research and studies need to be conducted to evaluate the evolution of AMR during the COVID-19 pandemic. This will be of utmost significance in developing countries that lack resistance pattern data and bear the additional burden of suboptimal treatment resources.
